Support Alert

Class 4 medicines defect information: Emerade 150, 300 and 500 microgram solution for injection in pre-filled syringe

The Medicines and Healthcare products Regulatory Agency (MHRA) has notified Bausch and Lomb UK Limited of reports that Emerade pens have failed to activate.

Loading...

Email newsletter

Want the latest pharmacy news and updates straight to your inbox?

Sign up to our regular newsletter for the latest guidance, news, events and CPD opportunities.

Sign Up